identification genes modify ataxin--induced neurodegeneration
growing number human neurodegenerative diseases result expansion glutamine repeat protein causes disease spinocerebellar ataxia type sca1 one disease-caused expansion polyglutamine tract protein ataxin- elucidate genetic pathways molecular mechanisms underlying neuronal degeneration group diseases created model system sca1 expressing full-length human sca1 gene drosophila show high levels wild-type ataxin can cause degenerative phenotypes similar caused expanded protein conducted genetic screens identify genes modify sca1-induced neurodegeneration several modifiers highlight role protein folding protein clearance development sca1 furthermore new mechanisms polyglutamine pathogenesis revealed discovery modifiers involved rna processing transcriptional regulation cellular detoxification findings may relevant treatment polyglutamine diseases perhaps neurodegenerative diseases alzheimers parkinsons disease
